TELA Bio, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TELA research report →
Companywww.telabio.com
TELA Bio, Inc. , a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs.
- CEO
- Antony Koblish
- IPO
- 2019
- Employees
- 209
- HQ
- Malvern, PA, US
Price Chart
Valuation
- Market Cap
- $41.83M
- P/E
- -1.34
- P/S
- 0.52
- P/B
- -10.29
- EV/EBITDA
- -1.78
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 67.25%
- Op Margin
- -41.84%
- Net Margin
- -49.30%
- ROE
- -1344.47%
- ROIC
- -64.94%
Growth & Income
- Revenue
- $80.28M · 15.84%
- Net Income
- $-38,831,000 · -2.62%
- EPS
- $-0.83 · 37.59%
- Op Income
- $-33,755,000
- FCF YoY
- 32.68%
Performance & Tape
- 52W High
- $2.20
- 52W Low
- $0.50
- 50D MA
- $0.77
- 200D MA
- $1.14
- Beta
- 1.30
- Avg Volume
- 183.72K
Get TickerSpark's AI analysis on TELA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 1, 26 | Langstein Howard N. | other | 0 |
| Mar 1, 26 | Langstein Howard N. | other | 72,750 |
| Feb 20, 26 | KOBLISH ANTONY | other | 176,000 |
| Feb 21, 26 | KOBLISH ANTONY | other | 12,494 |
| Feb 23, 26 | KOBLISH ANTONY | other | 11,631 |
| Feb 24, 26 | KOBLISH ANTONY | other | 3,900 |
| Feb 20, 26 | KOBLISH ANTONY | other | 261,000 |
| Feb 20, 26 | Firestone Gregory A. | other | 37,000 |
| Feb 21, 26 | Firestone Gregory A. | other | 4,189 |
| Feb 23, 26 | Firestone Gregory A. | other | 1,352 |
Our TELA Coverage
We haven't published any research on TELA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate TELA Report →